» Articles » PMID: 10886404

Modulation of the Immune Response to DNA Vaccine by Co-delivery of Costimulatory Molecules

Overview
Journal Immunology
Date 2000 Jul 11
PMID 10886404
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We have investigated methods for modulating immune responses, against herpes simplex virus (HSV), generated from DNA vaccination by co-delivery of genes encoding costimulatory molecules. A strong delayed-type hypersensitivity (DTH) reaction was induced in mice co-injected via the intradermal (i.d.) route with a eukaryotic expression plasmid encoding the CD80 molecule (pCD80) and a plasmid encoding the glycoprotein D of the HSV-2 (pgD). Furthermore, when spleen cells from these mice were cultured in the presence of inactivated HSV, a significant increase in the expression of interleukin-2 receptor (IL-2R) was observed in the CD4 subset compared with mice immunized only with pgD. Analysis of cytokine synthesis at the single-cell level indicated that CD80 genes induce a significant increase in the number of interferon-gamma (IFN-gamma)-, IL-2- and IL-4-secreting cells in the spleen. On the other hand, co-administration of the CD80 gene via the intramuscular (i.m.) route did not induce an increase in the cell-mediated immune response. When a plasmid carrying the CD86 gene (pCD86) was co-injected via the i.m. route with the pgD plasmid, a small decrease in the number of IFN-gamma-secreting cells was observed. This down-regulation of the immune response was also observed when eukaryotic expression cassettes for CD80 and for CD86 were co-administered with the pgD plasmid via the i.d. route. However, co-injection of pCD86 via the i.m. route produced a small increase in the number of IL-4-secreting cells. When immunized mice were challenged intravaginally with 100 plaque-forming units of virus, only co-injection of the CD80 gene by the i.d. route provoked an adjuvant effect compared with mice immunized with pgD alone. A reduction in the titres of HSV in vaginal washings was observed together with a decrease in the lesion score.

Citing Articles

Advances in nucleic acid-based cancer vaccines.

Liao H, Liu S J Biomed Sci. 2025; 32(1):10.

PMID: 39833784 PMC: 11748563. DOI: 10.1186/s12929-024-01102-w.


The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics.

Muslimov A, Tereshchenko V, Shevyrev D, Rogova A, Lepik K, Reshetnikov V Int J Mol Sci. 2023; 24(19).

PMID: 37834268 PMC: 10573212. DOI: 10.3390/ijms241914820.


The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions.

Brown S, Brown T, Cederna P, Rohrich R Plast Reconstr Surg Glob Open. 2020; 8(10):e3206.

PMID: 33173705 PMC: 7647601. DOI: 10.1097/GOX.0000000000003206.


Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus.

Farzani T, Hanifehnezhad A, Foldes K, Ergunay K, Yilmaz E, Hashim Mohamed Ali H Viruses. 2019; 11(1).

PMID: 30658445 PMC: 6356336. DOI: 10.3390/v11010075.


Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Jones C, Hakansson A, Pfeifer B J Mater Chem B. 2018; 46:8053-8068.

PMID: 29887986 PMC: 5990286. DOI: 10.1039/C4TB01058B.


References
1.
Gajewski T, Fallarino F, Uyttenhove C, Boon T . Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J Immunol. 1996; 156(8):2909-17. View

2.
Nicola A, Ponce de Leon M, Xu R, Hou W, Whitbeck J, Krummenacher C . Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol. 1998; 72(5):3595-601. PMC: 109580. DOI: 10.1128/JVI.72.5.3595-3601.1998. View

3.
Cohen G, Dietzschold B, Ponce de Leon M, Long D, Golub E, Varrichio A . Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol. 1984; 49(1):102-8. PMC: 255430. DOI: 10.1128/JVI.49.1.102-108.1984. View

4.
Petro T, Chen S, Panther R . Effect of CD80 and CD86 on T cell cytokine production. Immunol Invest. 1995; 24(6):965-76. DOI: 10.3109/08820139509060721. View

5.
Tang D, DeVit M, Johnston S . Genetic immunization is a simple method for eliciting an immune response. Nature. 1992; 356(6365):152-4. DOI: 10.1038/356152a0. View